Paloma Partners’s Array Biopharma Inc ARRY Stock Holding History

Paloma Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-54,202	Closed	-$2.51M	–	2457
2019 Q2	$2.51M	Buy	+54,202	New	+$1.52M	0.04%	338
2019 Q1	–	Sell	-19,400	Closed	-$276K	–	2079
2018 Q4	$276K	Buy	+19,400	New	+$294K	0.01%	894
2017 Q4	–	Sell	-35,866	Closed	-$441K	–	2468
2017 Q3	$441K	Buy	+35,866	New	+$333K	0.01%	1600
2016 Q4	–	Sell	-64,000	Closed	-$432K	–	2235
2016 Q3	$432K	Buy	+64,000	New	+$248K	0.01%	1482
2015 Q3	–	Sell	-15,729	Closed	-$113K	–	2093
2015 Q2	$113K	Buy	+15,729	New	+$116K	﹤0.01%	1666

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Paloma Partners's ARRY Position: Q3 2019 in Review

Paloma Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 54,202 shares — an estimated $2.51M sold.

Paloma Partners first reported a position in ARRY in Q2 2015 and held it in 5 quarters. The position peaked at $2.51M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Paloma Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Paloma Partners sold 54,202 Array Biopharma Inc shares in Q3 2019, an estimated $2.51M.
Paloma Partners first reported a position in Array Biopharma Inc in Q2 2015 and held it in 5 quarters.
Paloma Partners's Array Biopharma Inc position peaked at $2.51M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Paloma Partners's 13F filing for Q3 2019, filed 14 Nov 2019.